Amended Current Report Filing (8-k/a)
21 Mai 2019 - 12:07PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K/A
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): May 13, 2019
CELEXUS,
INC.
(Exact
name of registrant as specified in its charter)
Nevada
|
000-52069
|
98-0466350
|
(State
or other jurisdiction
|
(Commission
|
(IRS
Employer
|
of
incorporation)
|
File
Number)
|
Identification
Number)
|
8275
S. Eastern Ave. Suite 200
Las
Vegas, NV
|
88123
|
(Address
of principal executive offices)
|
(Zip
Code)
|
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[
] Written communications pursuant to Rule 425 under the Securities Act
[
] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
[
] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
[
] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company [X]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Explanatory
Note
On
May 13, 2019, Celexus, Inc. (the “Company”) filed a current report on Form 8-K which contained an incorrect statement
regarding the current status of the Company’s acquisition of HempWave, f/k/a Bio Distribution. The Company has entered into
a definitive agreement by which it will acquire HempWave subject to completion of an appraisal satisfactory to management of both
companies.
Item
5.02 Appointment of Certain Officers
HempWave,
a company to be acquired as a subsidiary by Celexus pursuant to certain acquisition terms, has appointed David Soto as its Chief
Executive Officer.
An
accomplished venture capitalist and startup leader with successful exits from thriving enterprises, Soto positions HempWave as
the principal figure in the growing hemp industry.
Since
2006, Soto has been a partner with Asturia Ventures, where his
strategic planning has
ensured the future growth of target markets and helped clients with raising capital, mergers and acquisitions, as well as transitions
and exit strategies.
Previously,
he was a senior partner with Benchmark Company, an investment advisory firm that developed investment management software to better
manage and grow its clients’ portfolios.
Item
9.01 Financial Statements and Exhibits
None.
SIGNATURES
Pursuant
to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
Dated: May
20, 2019
Celexus,
Inc.
/s/
Lisa Averbuch
Lisa
Averbuch, President
Celexus (CE) (USOTC:CXUS)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Celexus (CE) (USOTC:CXUS)
Historical Stock Chart
Von Jun 2023 bis Jun 2024